Clinical Trial Update: Amyloid-beta PET Imaging With 18F-92 in Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for amyloid-beta PET imaging tracer 18F-92 in Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• 18F-92

Snippet

Sponsor: First Affiliated Hospital of Fujian Medical University | Conditions: Alzheimer's Disease | Phase 2 | Status: UNKNOWN